Rafferty Asset Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
Rafferty Asset Management's ONCE Position: Q4 2019 in Review
Rafferty Asset Management sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 61,872 shares — an estimated $6M sold.
Rafferty Asset Management first reported a position in ONCE in Q1 2019 and held it in 3 quarters. The position peaked at $6M in Q3 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.
- Rafferty Asset Management reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
- Rafferty Asset Management sold 61,872 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $6M.
- Rafferty Asset Management first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2019 and held it in 3 quarters.
- Rafferty Asset Management's Spark Therapeutics, Inc. Common Stock position peaked at $6M in Q3 2019.
- 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.
Based on Rafferty Asset Management's 13F filing for Q4 2019, filed 10 Feb 2020.